Tratamiento con fármacos antiangiogénicos de la degeneración macular asociada a la edad exudativa: análisis de la función visual a largo plazo en la práctica clínica habitual

Purpose: To analyze the long-term visual outcomes of vascular endothelial growth factor inhibitors in treatment-naïve eyes with neovascular age-related macular degeneration (AMD). Methods: Retrospective study with 48 eyes of 44 treatment-naïve patients with neovascular AMD treated only with anti-angiogenic. Visual acuity (VA) results were analyzed after 6 months and 1, 3, and 5 years of follow-up. results: Mean VA improved from 61.04 to 65.83 letters after 6 months, with a loss of −1.14, −16.88 and −27.50 letters compared to baseline after 1, 3 and 5 years. The proportion of eyes that lost < 15 letters at 3 and 5 years was 50% and 33.3%, respectively. The proportion of eyes with a gain of > 15 letters was 14.6% and 12.5% at 3 and Si n co nt ar c on e l c on se nt im ie nt o pr ev io p or e sc ri to d el e di to r, no p od rá r ep ro du ci rs e ni f ot oc op ia rs e ni ng un a pa rt e de e st a pu bl ic ac ió n. © P er m an ye r 20 20 Rev Mex OftalMOl. 2020;94(5)